BRISTOL-MYERS SQUIBB COMPANY Gross Profit
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Gross Profit of $8.16 billion for the 3-month period ending 2020-12-31, per its 10-K filed 2021-02-10.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2021-02-10
- BRISTOL-MYERS SQUIBB COMPANY gross profit for the quarter ending 2020-12-31 was $8.16B, a 49.61% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for the quarter ending 2020-09-30 was $8.04B, a 90.61% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for the quarter ending 2020-06-30 was $7.43B, a 72.75% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for the quarter ending 2020-03-31 was $7.12B, a 73.80% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for fiscal 2020 was $30.75B, a 70.17% increase from fiscal 2019.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for fiscal 2019 was $18.07B, a 12.26% increase from fiscal 2018.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for fiscal 2018 was $16.09B, a 9.62% increase from fiscal 2017.
- BRISTOL-MYERS SQUIBB COMPANY gross profit for fiscal 2017 was $14.68B, a 1.39% increase from fiscal 2016.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|
| 2020-12-31 | $8.16B 10-K · filed 2021-02-10 | $16.20B derived: sum of 2 quarters · filed 2021-02-10 | $23.63B derived: sum of 3 quarters · filed 2021-02-10 | $30.75B 10-K · filed 2021-02-10 | ||
| 2020-09-30 | $8.04B 10-K · filed 2021-02-10 | $15.47B derived: sum of 2 quarters · filed 2021-02-10 | $22.59B derived: sum of 3 quarters · filed 2021-02-10 | $28.04B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2020-06-30 | $7.43B 10-K · filed 2021-02-10 | $14.55B derived: sum of 2 quarters · filed 2021-02-10 | $20.00B derived: sum of 3 quarters · filed 2021-02-10 | $24.22B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2020-03-31 | $7.12B 10-K · filed 2021-02-10 | $12.57B derived: sum of 2 quarters · filed 2021-02-10 | $16.79B derived: sum of 3 quarters · filed 2021-02-10 | $21.09B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-12-31 | $5.45B 10-K · filed 2021-02-10 | $9.67B derived: sum of 2 quarters · filed 2021-02-10 | $13.97B derived: sum of 3 quarters · filed 2021-02-10 | $18.07B 10-K · filed 2021-02-10 | ||
| 2019-09-30 | $4.22B 10-K · filed 2021-02-10 | $8.52B derived: sum of 2 quarters · filed 2021-02-10 | $12.61B derived: sum of 3 quarters · filed 2021-02-10 | $16.92B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-06-30 | $4.30B 10-K · filed 2021-02-10 | $8.40B derived: sum of 2 quarters · filed 2021-02-10 | $12.70B derived: sum of 3 quarters · filed 2021-02-10 | $16.76B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2019-03-31 | $4.10B 10-K · filed 2021-02-10 | $8.40B derived: sum of 2 quarters · filed 2021-02-10 | $12.46B derived: sum of 3 quarters · filed 2021-02-10 | $16.56B derived: sum of 4 quarters · filed 2021-02-10 | ||
| 2018-12-31 | $4.30B 10-K · filed 2020-02-24 | $4.28B 10-K · filed 2019-02-25 | $8.37B derived: sum of 2 quarters · filed 2020-02-24 | $12.46B derived: sum of 3 quarters · filed 2020-02-24 | $16.09B 10-K · filed 2020-02-24 | $16.01B 10-K · filed 2019-02-25 |
| 2018-09-30 | $4.06B 10-K · filed 2020-02-24 | $4.04B 10-K · filed 2019-02-25 | $8.16B derived: sum of 2 quarters · filed 2020-02-24 | $11.79B derived: sum of 3 quarters · filed 2020-02-24 | $15.56B derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-06-30 | $4.10B 10-K · filed 2020-02-24 | $4.08B 10-K · filed 2019-02-25 | $7.73B derived: sum of 2 quarters · filed 2020-02-24 | $11.50B derived: sum of 3 quarters · filed 2020-02-24 | $15.17B derived: sum of 4 quarters · filed 2020-02-24 | |
| 2018-03-31 | $3.63B 10-K · filed 2020-02-24 | $3.61B 10-K · filed 2019-02-25 | $7.40B derived: sum of 2 quarters · filed 2020-02-24 | $11.07B derived: sum of 3 quarters · filed 2020-02-24 | $14.65B derived: sum of 4 quarters · filed 2020-02-24 | |
| 2017-12-31 | $3.77B 10-K · filed 2019-02-25 | $3.78B 10-K · filed 2018-02-13 | $7.44B derived: sum of 2 quarters · filed 2019-02-25 | $11.02B derived: sum of 3 quarters · filed 2019-02-25 | $14.68B 10-K · filed 2019-02-25 | $14.71B 10-K · filed 2018-02-13 |
| 2017-09-30 | $3.67B 10-K · filed 2019-02-25 | $3.68B 10-K · filed 2018-02-13 | $7.25B derived: sum of 2 quarters · filed 2019-02-25 | $10.91B derived: sum of 3 quarters · filed 2019-02-25 | $14.77B derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-06-30 | $3.58B 10-K · filed 2019-02-25 | $3.58B 10-K · filed 2018-02-13 | $7.24B derived: sum of 2 quarters · filed 2019-02-25 | $11.10B derived: sum of 3 quarters · filed 2019-02-25 | $14.72B derived: sum of 4 quarters · filed 2019-02-25 | |
| 2017-03-31 | $3.66B 10-K · filed 2019-02-25 | $3.67B 10-K · filed 2018-02-13 | $7.52B derived: sum of 2 quarters · filed 2019-02-25 | $11.14B derived: sum of 3 quarters · filed 2019-02-25 | $14.81B derived: sum of 4 quarters · filed 2019-02-25 | |
| 2016-12-31 | $3.86B 10-K · filed 2018-02-13 | $7.48B derived: sum of 2 quarters · filed 2018-02-13 | $11.14B derived: sum of 3 quarters · filed 2018-02-13 | $14.48B 10-K · filed 2018-02-13 | ||
| 2016-09-30 | $3.62B 10-K · filed 2018-02-13 | $7.28B derived: sum of 2 quarters · filed 2018-02-13 | $10.62B derived: sum of 3 quarters · filed 2018-02-13 | $13.96B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | $3.67B 10-K · filed 2018-02-13 | $7.00B derived: sum of 2 quarters · filed 2018-02-13 | $10.34B derived: sum of 3 quarters · filed 2018-02-13 | $13.31B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | $3.34B 10-K · filed 2018-02-13 | $6.67B derived: sum of 2 quarters · filed 2018-02-13 | $9.65B derived: sum of 3 quarters · filed 2018-02-13 | $12.80B derived: sum of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | $3.33B 10-K · filed 2017-02-21 | $6.31B derived: sum of 2 quarters · filed 2017-02-21 | $9.46B derived: sum of 3 quarters · filed 2017-02-21 | $12.65B 10-K · filed 2017-02-21 | ||
| 2015-09-30 | $2.97B 10-K · filed 2017-02-21 | $6.12B derived: sum of 2 quarters · filed 2017-02-21 | $9.32B derived: sum of 3 quarters · filed 2017-02-21 | $12.61B derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-06-30 | $3.15B 10-K · filed 2017-02-21 | $6.34B derived: sum of 2 quarters · filed 2017-02-21 | $9.64B derived: sum of 3 quarters · filed 2017-02-21 | $12.55B derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2015-03-31 | $3.19B 10-K · filed 2017-02-21 | $6.49B derived: sum of 2 quarters · filed 2017-02-21 | $9.40B derived: sum of 3 quarters · filed 2017-02-21 | $12.30B derived: sum of 4 quarters · filed 2017-02-21 | ||
| 2014-12-31 | $3.29B 10-K · filed 2016-02-12 | $6.21B derived: sum of 2 quarters · filed 2016-02-12 | $9.10B derived: sum of 3 quarters · filed 2016-02-12 | $11.95B 10-K · filed 2016-02-12 | ||
| 2014-09-30 | $2.91B 10-K · filed 2016-02-12 | $5.81B derived: sum of 2 quarters · filed 2016-02-12 | $8.65B derived: sum of 3 quarters · filed 2016-02-12 | $11.82B derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-06-30 | $2.90B 10-K · filed 2016-02-12 | $5.74B derived: sum of 2 quarters · filed 2016-02-12 | $8.91B derived: sum of 3 quarters · filed 2016-02-12 | $11.80B derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-03-31 | $2.84B 10-K · filed 2016-02-12 | $6.01B derived: sum of 2 quarters · filed 2016-02-12 | $8.90B derived: sum of 3 quarters · filed 2016-02-12 | $11.84B derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2013-12-31 | $3.17B 10-K · filed 2015-02-13 | $6.06B derived: sum of 2 quarters · filed 2015-02-13 | $9.00B derived: sum of 3 quarters · filed 2015-02-13 | $11.77B 10-K · filed 2015-02-13 | ||
| 2013-09-30 | $2.89B 10-K · filed 2015-02-13 | $5.83B derived: sum of 2 quarters · filed 2015-02-13 | $8.60B derived: sum of 3 quarters · filed 2015-02-13 | $11.71B derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | $2.94B 10-K · filed 2015-02-13 | $5.71B derived: sum of 2 quarters · filed 2015-02-13 | $8.82B derived: sum of 3 quarters · filed 2015-02-13 | $11.57B derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-03-31 | $2.77B 10-K · filed 2015-02-13 | $5.88B derived: sum of 2 quarters · filed 2015-02-13 | $8.63B derived: sum of 3 quarters · filed 2015-02-13 | $11.83B derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2012-12-31 | $3.12B 10-K · filed 2014-02-14 | $5.87B derived: sum of 2 quarters · filed 2014-02-14 | $9.06B derived: sum of 3 quarters · filed 2014-02-14 | $13.01B 10-K · filed 2014-02-14 | ||
| 2012-09-30 | $2.75B 10-K · filed 2014-02-14 | $5.95B derived: sum of 2 quarters · filed 2014-02-14 | $9.89B derived: sum of 3 quarters · filed 2014-02-14 | $13.98B derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-06-30 | $3.20B 10-K · filed 2014-02-14 | $7.15B derived: sum of 2 quarters · filed 2014-02-14 | $11.23B derived: sum of 3 quarters · filed 2014-02-14 | $15.17B derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-03-31 | $3.95B 10-K · filed 2014-02-14 | $8.04B derived: sum of 2 quarters · filed 2014-02-14 | $11.97B derived: sum of 3 quarters · filed 2014-02-14 | $15.93B derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2011-12-31 | $4.09B 10-K · filed 2013-02-15 | $8.03B derived: sum of 2 quarters · filed 2013-02-15 | $11.98B derived: sum of 3 quarters · filed 2013-02-15 | $15.65B 10-K · filed 2013-02-15 | ||
| 2011-09-30 | $3.94B 10-K · filed 2013-02-15 | $7.89B derived: sum of 2 quarters · filed 2013-02-15 | $11.56B derived: sum of 3 quarters · filed 2013-02-15 | $15.26B derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2011-06-30 | $3.95B 10-K · filed 2013-02-15 | $7.62B derived: sum of 2 quarters · filed 2013-02-15 | $11.32B derived: sum of 3 quarters · filed 2013-02-15 | $14.84B derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2011-03-31 | $3.67B 10-K · filed 2013-02-15 | $7.37B derived: sum of 2 quarters · filed 2013-02-15 | $10.88B derived: sum of 3 quarters · filed 2013-02-15 | $14.37B derived: sum of 4 quarters · filed 2013-02-15 | ||
| 2010-12-31 | $3.70B 10-K · filed 2012-02-17 | $7.21B derived: sum of 2 quarters · filed 2012-02-17 | $10.71B derived: sum of 3 quarters · filed 2012-02-17 | $14.21B 10-K · filed 2012-02-17 | ||
| 2010-09-30 | $3.52B 10-K · filed 2012-02-17 | $7.01B derived: sum of 2 quarters · filed 2012-02-17 | $10.51B derived: sum of 3 quarters · filed 2012-02-17 | $14.11B derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-06-30 | $3.49B 10-K · filed 2012-02-17 | $6.99B derived: sum of 2 quarters · filed 2012-02-17 | $10.59B derived: sum of 3 quarters · filed 2012-02-17 | $14.06B derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2010-03-31 | $3.50B 10-K · filed 2012-02-17 | $7.10B derived: sum of 2 quarters · filed 2012-02-17 | $10.57B derived: sum of 3 quarters · filed 2012-02-17 | $14.01B derived: sum of 4 quarters · filed 2012-02-17 | ||
| 2009-12-31 | $3.60B 10-K · filed 2011-02-18 | $7.07B derived: sum of 2 quarters · filed 2011-02-18 | $10.51B derived: sum of 3 quarters · filed 2011-02-18 | $13.67B 10-K · filed 2011-02-18 | ||
| 2009-09-30 | $3.47B 10-K · filed 2011-02-18 | $6.91B derived: sum of 2 quarters · filed 2011-02-18 | $10.07B derived: sum of 3 quarters · filed 2011-02-18 | |||
| 2009-06-30 | $3.44B 10-K · filed 2011-02-18 | $6.60B derived: sum of 2 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $3.16B 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |